Which measure was used in the 2012 study to evaluate the global burden of disease?

Which measure was used in the 2012 study to evaluate the global burden of disease?

• A. Life expectancy
• B. Quality Adjusted Life Year (QALY)
• C. Disability-adjusted Life Year (DALY)
• D. Health-related Quality of Life (HRQoL)

Answer: (C)

The measure used in the 2012 study to evaluate the global burden of disease was the Disability-adjusted Life Year (DALY). This metric is specifically designed to quantify the overall disease burden by combining the impact of both premature death and the time spent in poor health. One DALY represents the loss of the equivalent of one year of full health. Therefore, this measure allows for an assessment of both mortality (through years of life lost) and morbidity (through years lived with disability), providing a more comprehensive view of public health than simply looking at life expectancy or quality of life in isolation. The use of DALYs enables comparisons across different diseases and conditions, contributing to a better understanding of how various health issues affect populations globally. This is particularly helpful for policymakers and health organizations in prioritizing resource allocation and intervention strategies. By capturing both aspects of health – length and quality of life – DALYs help inform decisions in health systems worldwide regarding interventions and health policy planning.

The measure used in the 2012 study to evaluate the global burden of disease was the Disability-adjusted Life Year (DALY). This metric is specifically designed to quantify the overall disease burden by combining the impact of both premature death and the time spent in poor health. One DALY represents the loss of the equivalent of one year of full health. Therefore, this measure allows for an assessment of both mortality (through years of life lost) and morbidity (through years lived with disability), providing a more comprehensive view of public health than simply looking at life expectancy or quality of life in isolation.

The use of DALYs enables comparisons across different diseases and conditions, contributing to a better understanding of how various health issues affect populations globally. This is particularly helpful for policymakers and health organizations in prioritizing resource allocation and intervention strategies. By capturing both aspects of health – length and quality of life – DALYs help inform decisions in health systems worldwide regarding interventions and health policy planning.